TipRanks
Enlivex Therapeutics Ltd (DE:1BT)
FRANKFURT:1BT
Germany Market
1BT
Enlivex
RESEARCH TOOLSreports

Enlivex (1BT) Ratios

0 Followers

Enlivex Ratios

DE:1BT's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, DE:1BT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 119.39 193.24 6.84 5.57 7.92
Quick Ratio
 119.39 193.24 6.84 5.57 7.74
Cash Ratio
 0.18 0.22 0.87 0.13 7.24
Solvency Ratio
 4.10 3.15 -3.53 -4.18 -2.80
Operating Cash Flow Ratio
 -0.50 -1.15 -3.42 -3.88 -3.63
Short-Term Operating Cash Flow Coverage
 -0.94 0.00 -55.35 0.00 0.00
Net Current Asset Value
$ 2.75B$ 1.35B$ 21.89M$ 27.02M$ 41.53M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.02 0.03 0.07
Debt-to-Equity Ratio
 <0.01 <0.01 0.02 0.03 0.09
Debt-to-Capital Ratio
 <0.01 <0.01 0.02 0.03 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.26 1.20 1.17 1.22 1.19
Debt Service Coverage Ratio
 -74.83 -30.56K -58.34 -2.02K -4.75
Interest Coverage Ratio
 0.00 -1.15K -1.20K -2.10K -4.90
Debt to Market Cap
 1.95 0.00 <0.01 0.00 0.00
Interest Debt Per Share
 0.89 0.21 0.03 0.06 0.55
Net Debt to EBITDA
 -0.59 0.09 0.19 >-0.01 1.72
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
76.77%76.35%100.00%100.00%100.00%
EBT Per EBIT
-26016.21%-10787.83%96.64%98.89%120.40%
Return on Assets (ROA)
83.82%53.10%-54.23%-78.92%-45.92%
Return on Equity (ROE)
279.88%63.85%-63.65%-96.62%-54.64%
Return on Capital Employed (ROCE)
-0.42%-0.65%-65.04%-95.53%-42.27%
Return on Invested Capital (ROIC)
-0.32%-0.49%-63.78%-94.47%-41.82%
Return on Tangible Assets
83.82%70.82%-54.23%-78.92%-45.92%
Earnings Yield
41312.46%3844.25%-62.55%-57.96%-42.86%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.09 0.09 0.67 1.01 0.40
Inventory Turnover
 0.00 0.00 0.00 0.00 0.66
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -3.94K -4.19K -543.15 -361.50 -362.18
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 552.90
Days of Payables Outstanding
 3.94K 4.19K 543.15 361.50 915.08
Operating Cycle
 0.00 0.00 0.00 0.00 552.90
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.82 -3.42 -0.63 -1.27 -1.30
Free Cash Flow Per Share
 -0.84 -3.44 -0.64 -1.28 -1.74
CapEx Per Share
 <0.01 0.02 <0.01 0.01 0.44
Free Cash Flow to Operating Cash Flow
 1.02 1.01 1.01 1.01 1.34
Dividend Paid and CapEx Coverage Ratio
 -376.87 -153.18 -126.29 -99.67 -2.95
Capital Expenditure Coverage Ratio
 -376.87 -153.18 -126.29 -99.67 -2.95
Operating Cash Flow Coverage Ratio
 -0.92 -16.25 -24.36 -22.79 -4.94
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-186.95%-32.62%-54.63%-47.37%-44.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 <0.01 0.03 -1.60 -1.73 -2.33
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 <0.01 0.02 1.02 1.67 1.28
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.53 -3.07 -1.83 -2.11 -2.26
Price-to-Operating Cash Flow Ratio
 -0.63 -3.09 -1.85 -2.13 -3.03
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.03 0.05 >-0.01
Price-to-Fair Value
 <0.01 0.02 1.02 1.67 1.28
Enterprise Value Multiple
 -1.02 -2.10 -1.47 -1.78 -1.18
Enterprise Value
 20.38M 30.77M 21.23M 50.37M 29.50M
EV to EBITDA
 -1.02 -2.10 -1.47 -1.78 -1.18
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -1.26 -2.94 -1.62 -2.12 -0.92
EV to Operating Cash Flow
 -1.29 -2.95 -1.63 -2.14 -1.23
Tangible Book Value Per Share
 201.55 443.95 1.15 1.62 3.09
Shareholders’ Equity Per Share
 201.55 635.16 1.15 1.62 3.09
Tax and Other Ratios
Effective Tax Rate
 0.23 0.24 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 212.35 405.57 -0.73 -1.56 -1.69
Tax Burden
 0.77 0.76 1.00 1.00 1.00
Interest Burden
 -264.69 -107.88 1.00 1.00 1.20
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 >-0.01 >-0.01 0.87 0.81 0.77
Currency in USD